Akut limfoid leukémia (ALL): vizsgálatok itt: Németország
35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Aachen, Augsburg, Bad Saarow, Berlin, Bonn, Chemnitz, Dresden, Erlangen, Frankfurt Am Main, Freiburg im Breisgau, Halle (Saale), Hamburg, Jena, Kiel, Leipzig, Mannheim, Marburg, Muenchen, Munich, Regensburg, Ulm, Wuerzburg
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1. fázisTaking peopleA Phase I Dose Finding Study of MB-CART2219.1
- Where
- Tuebingen
- Életkor
- 12 év to 75 év
- People
- 36
- Run by
- University Hospital Tuebingen
See details and how to joinNCT07108868 · EU 2024-516838-35-00 - 3. fázisTaking peopleA Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
- Where
- Muenster
- Életkor
- 1 év to 64 év
- People
- 130 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07223021 · EU 2025-523096-34-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Berlin, Cologne, Giessen, Muenster, Tuebingen
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - No phaseTaking peopleMore Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)
- Where
- Erlangen
- Életkor
- 3 év and over
- People
- 180
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT07705178 - 3. fázisTaking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Berlin
- Életkor
- 1 év to 64 év
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Dresden, Frankfurt Am Main, Halle (Saale), Heidelberg, Munich, Ulm
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 2/3. fázisTaking peopleFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Frankfurt
- Életkor
- 3 hónap to 25 év
- People
- 1000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Aachen, Augsburg, Berlin, Bonn, Bremen, Cologne, Dortmund, Dresden, Duesseldorf, Erlangen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Halle Saale, Hamburg, Hanover, Heidelberg, Kiel, Krefeld, Mainz, Muenster, Munich, Stuttgart, Tuebingen, Ulm
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - 3. fázisTaking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Giessen, Mainz
- Életkor
- 18 év and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Berlin, Cologne, Duesseldorf, Essen, Frankfurt Am Main, Freiburg im Breisgau, Halle (Saale), Hamburg, Kiel, Muenster, Munich, Wuerzburg
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Hamburg, Leipzig, Mainz, Ulm
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1/2. fázisTaking peopleLong-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
- Where
- Berlin, Cologne, Erlangen, Goettingen, Muenster, Munich, Tuebingen, Wuerzburg
- People
- 40
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508775 · EU 2022-501648-14-00 - 1/2. fázisNot yet taking people in NémetországStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Berlin, Cologne, Erlangen, Essen, Frankfurt Am Main, Hamburg
- Életkor
- Up to 64 év
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00 · EU 2025-522019-40-00 - 2. fázisTaking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Berlin, Duesseldorf, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Hamburg, Hanover, Jena, Kiel, Muenster, Tuebingen, Ulm, Wuerzburg
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - 3. fázisNot yet taking people in NémetországAIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
- Where
- Aachen, Augsburg, Berlin, Brunswick, Chemnitz, Cologne, Cottbus, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle (Saale), Hanover, Heidelberg, Heilbronn, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Luebeck, Magdeburg, Mannheim, Minden, Muenster, Munich, Nuernberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Witten, Wolfsburg, Wuerzburg
- Életkor
- Up to 17 év
- People
- 2250
- Run by
- Universitaetsklinikum Schleswig-Holstein AöR
See details and how to join2025-522190-11-01 · EU 2025-522190-11-01 - 2/3. fázisTaking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Aachen, Berlin, Bonn, Duesseldorf, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Greifswald, Halle (Saale), Hamburg, Hanover, Heidelberg, Jena, Kiel, Leipzig, Muenster, Munich, Regensburg, Tuebingen, Ulm, Wuerzburg
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - 2. fázisTaking peopleIsatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia
- Where
- Augsburg, Berlin, Bremen, Dresden, Duesseldorf, Erlangen, Essen, Frankfurt Am Main, Goettingen, Hamburg, Heidelberg, Kiel, Leipzig, Muenster, Munich, Oldenburg, Stuttgart, Ulm
- Életkor
- 18 év and over
- People
- 28
- Run by
- Goethe University
See details and how to joinNCT06648889 · EU 2023-507899-47-00 - 3. fázisTaking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Bielefeld, Bonn, Bremen, Hamburg, Krefeld, Mainz
- Életkor
- 0 év to 45 év
- People
- 6430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - No phaseTaking peopleGMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
- Where
- Aachen, Altenburg, Altötting, Aschaffenburg, Augsburg, Bad Saarow, Bamberg, Bayreuth, Berlin, Bielefeld, Bochum, Bonn, Braunschweig, Bremen, Chemnitz, Cologne, Cottbus, Darmstadt, Dessau, Dortmund, Dresden, Duisburg, Düren, Düsseldorf, Erfurt, Erlangen, Eschweiler, Essen, Flensburg, Frankfurt, Frankfurt am Main, Freiburg im Breisgau, Fulda, Georgsmarienhütte, Giessen, Goch, Göttingen, Greifswald, Gütersloh, Hagen, Halle, Hamburg, Hamm, Hanover, Heidelberg, Heilbronn, Herne, Hildesheim, Homburg/Saar, Idar-Oberstein, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Krefeld, Kulmbach, Landshut, Leipzig, Lippe, Lübeck, Lüdenscheid, Ludwigshafen, Magdeburg, Mainz, Mannheim, Marburg, Meschede, Minden, Mönchengladbach, München, Münster, Mutlangen, Neubrandenburg, Nordhausen, Nuremberg, Offenburg, Oldenburg, Osnabrück, Paderborn, Passau, Potsdam, Recklinghausen, Regensburg, Reutlingen, Riesa, Rostock, Rotenburg (Wümme), Saarlouis, Sande, Schwäbisch Hall, Schwerin, Siegen, Sindelfingen, Speyer, Stuttgart, Traunstein, Trier, Tübingen, Ulm, Villingen-Schwenningen, Wiesbaden, Winnenden, Wolfsburg, Wuppertal, Würzburg, Zwickau
- Életkor
- 18 év and over
- People
- 10 000 worldwide
- Run by
- Goethe University
See details and how to joinNCT02872987 - 2. fázisNot yet taking people in NémetországA PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL
- Where
- Frankfurt Am Main
- People
- 86 worldwide
- Run by
- Centre Hospitalier De Versailles
See details and how to join2024-516570-30-00 · EU 2024-516570-30-00 - 1/2. fázisTaking peopleInotuzumab ozogamicin for Acute Lymphoblastic Leukemia
- Where
- Berlin, Essen, Frankfurt Am Main, Muenster
- Életkor
- Up to 17 év
- People
- 142 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504694-20-00 · EU 2023-504694-20-00 - 3. fázisTaking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Aachen, Augsburg, Berlin, Bremen, Dortmund, Dresden, Düsseldorf, Erlangen, Essen, Frankfurt, Freiburg im Breisgau, Giessen, Hamburg, Hannover, Heidelberg, Homburg, Kiel, Leipzig, Mainz, Münster, Stuttgart, Tübingen, Ulm
- Életkor
- Up to 64 év
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 · EU 2025-520982-39-00 - 3. fázisTaking peopleA Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Where
- Dresden, Hamburg, Stuttgart
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00 - 2. fázisTaking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle Saale, Hamburg, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Magdeburg, Mainz, Muenster, Munich, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 17 év
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00